Evidence map›Paper›PMID 28216189›Full record

ArticleVaccine2017

Rotavirus immunization: Global coverage and local barriers for implementation.

Andrea Lo Vecchio, Ilaria Liguoro, Jorge Amil Dias, James A Berkley, Chris Boey, Mitchell B Cohen, Sylvia Cruchet, Eduardo Salazar-Lindo, Samir Podder, Bhupinder Sandhu and 3 more

Registry-linked trialAbstract read
In one paragraph

Article in Vaccine, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT05212935 (A Surveillance Study on Timing and Coverage Of Rotavirus and MenB Vaccine Co-administration in Campania Region, Italy), which is not on this map. Cited by 19 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT05212935 unknown statusnot on this mapstarted 2022, after this paper: background citation

A Surveillance Study on Timing and Coverage Of Rotavirus and MenB Vaccine Co-administration in Campania Region, Italy

TypeobservationalSponsorFederico II UniversityRan2022 to 2023Enrolled2,000ConditionsVaccination, Rotavirus Infections, Meningococcal InfectionsArmsRotavirus Vaccine
3 · Its place in the literature

Who cites it

19 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Review
  3. Acute Infectious Diarrhea.Advances in experimental medicine and biology · 2024
    Review
  4. Article
  5. Article
  6. Frontiers in cellular and infection microbiology · 2022
    Article
  7. Review
  8. Article
  9. Article
  10. Acute Gastroenteritis in Children of the World: What Needs to Be Done?Journal of pediatric gastroenterology and nutrition · 2020
    Article
  11. Article
  12. Article
  13. Review
  14. Rotavirus Infection and Vaccination: Knowledge, Beliefs, and Behaviors among Parents in Italy.International journal of environmental research and public health · 2019
    Article
  15. Article
  16. Pediatric Dehydration Assessment at Triage: Prospective Study on Refilling Time.Pediatric gastroenterology, hepatology & nutrition · 2018
    Article
  17. Article
  18. Review
  19. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors.

Andrea Lo VecchioSection of Pediatrics, Department of Translational Medical Sciences, University of Naples Federico II, Naples, Italy.
Ilaria LiguoroDepartment of Clinical and Experimental Medical Sciences, University Hospital of Udine, Udine, Italy.
Jorge Amil DiasDepartamento de Pediatria Médica, Hospital de São João, Porto, Portugal.
James A BerkleyKEMRI/Wellcome Trust Research Programme, Kilifi, Kenya.
Chris BoeyFaculty of Medicine, University of Malaya, Kuala Lumpur, Malaysia.
Mitchell B CohenDepartment of Pediatrics, University of Alabama at Birmingham, Birmingham, AL, USA.
Sylvia CruchetInstituto de nutrición y tecnología de los alimentos, INTA, Universidad de Chile, Santiago, Chile.
Eduardo Salazar-LindoDepartment of Pediatrics, Universidad Peruana Cayetano Heredia, Lima, Peru.
Samir PodderMedical and Scientific Affairs, Innovara, Inc., MA, United States.
Bhupinder SandhuDepartment of Paediatric Gastroenterology, Bristol Royal Hospital for Children, Bristol, United Kingdom.
Philip M ShermanDepartment of Paediatrics, Hospital for Sick Children, University of Toronto, Toronto, Canada.
Toshiaki ShimizuDepartment of Pediatrics and Adolescent Medicine, Juntendo University Graduate School of Medicine, Tokyo, Japan.
Alfredo GuarinoSection of Pediatrics, Department of Translational Medical Sciences, University of Naples Federico II, Naples, Italy. Electronic address: alfguari@unina.it.

Funding

Wellcome Trust 203077
6 · The paper itself

Abstract

backgroundRotavirus (RV) is a major agent of gastroenteritis and an important cause of child death worldwide. Immunization (RVI) has been available since 2006, and the Federation of International Societies of Gastroenterology Hepatology and Nutrition (FISPGHAN) identified RVI as a top priority for the control of diarrheal illness. A FISPGHAN working group on acute diarrhea aimed at estimating the current RVI coverage worldwide and identifying barriers to implementation at local level.

methodsA survey was distributed to national experts in infectious diseases and health-care authorities (March 2015-April 2016), collecting information on local recommendations, costs and perception of barriers for implementation.

resultsForty-nine of the 79 contacted countries (62% response rate) provided a complete analyzable data. RVI was recommended in 27/49 countries (55%). Although five countries have recommended RVI since 2006, a large number (16, 33%) included RVI in a National Immunization Schedule between 2012 and 2014. The costs of vaccination are covered by the government (39%), by the GAVI Alliance (10%) or public and private insurance (8%) in some countries. However, in most cases, immunization is paid by families (43%). Elevated cost of vaccine (49%) is the main barrier for implementation of RVI. High costs of vaccination (rs=-0.39, p=0.02) and coverage of expenses by families (rs=0.5, p=0.002) significantly correlate with a lower immunization rate. Limited perception of RV illness severity by the families (47%), public-health authorities (37%) or physicians (24%) and the timing of administration (16%) are further major barriers to large- scale RVI programs.

conclusionsAfter 10years since its introduction, the implementation of RVI is still unacceptably low and should remain a major target for global public health. Barriers to implementation vary according to setting. Nevertheless, public health authorities should promote education for caregivers and health-care providers and interact with local health authorities in order to implement RVI.

Indexed as

Vaccination CoverageGastroenteritisGlobal HealthHumansRotavirus InfectionsRotavirus VaccinesSurveys and QuestionnairesRotavirus VaccinesDiarrheaImmunizationImplementationRotavirusVaccine

Identifiers

PMID28216189
PMCPMC6624129

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.